Skip to main content

Marketing authorisation for Covishield will be considered when application is received, says EU agency

New Delhi: The Covishield vaccine "does not currently have a marketing authorisation" in Europe and the matter would be considered when an application is received for it, the European Medicines Agency (EMA) said on Monday.

People vaccinated with Covishield, manufactured by Pune-based Serum Institute of India (SII), are unlikely to be eligible to travel to the European Union member states under the 'Green Pass' scheme as the vaccine is yet to be cleared by the EMA.

The EU Digital COVID certificate or 'Green Pass' will be mandatory to travel to European countries and the document is likely to serve as proof that a person is vaccinated against COVID-19.

Travel under 'Green Pass' to non-EU citizens may be rolled out in a phased manner from 1 July.

However, individual European Union member countries may have separate rules and norms for travellers.

The EMA has already approved four COVID-19 vaccines which included Vaxzevria, the AstraZeneca vaccine manufactured in the UK and EU-member countries.

The SII makes Covishield in India with a licence from AstraZeneca.

"The only COVID-19 vaccine from AstraZeneca for which a marketing authorisation application was submitted to and evaluated by EMA, leading to its authorisation in the EU, is Vaxzevria," Alessandro Faia, a spokesperson of the EMA said.

"In the EU, the vaccine called Covishield does not currently have a marketing authorisation. Even though it may use an analogous production technology to Vaxzevria (the COVID-19 AstraZeneca vaccine authorised in the EU), Covishield as such is not currently approved under EU rules," the official said.

Explaining the reason, the official said even tiny differences in the manufacturing conditions can result in differences in the final product.

"This is because vaccines are biological products. Even tiny differences in the manufacturing conditions can result in differences in the final product, and EU law, therefore, requires the manufacturing sites and production process to be assessed and approved as part of the authorisation process," the spokesperson said.

"Should we receive a marketing authorisation application for Covishield or should any change to the approved manufacturing sites for Vaxzevria be approved, we would communicate about it," he said.

The official clarified that the EMA is not responsible for any decision regarding travelling into the EU and the travelling conditions associated with COVID-19 vaccination, such as the EU Digital COVID certificate.

"This is a matter for the European Commission and for individual member states," the official added.



from Firstpost India Latest News https://ift.tt/3qw3ZGB
Labels:

Comments

Post a Comment

Popular posts from this blog

COVID-19 vaccination: Registration for citizens above 18 years of age starts today on CoWin, Aarogya Setu portals

The registration for COVID-19 vaccination for people above the age of 18 years in India started from today ( Wednesday, 28 April ). Those who are eligible for vaccination can register themselves on two applications, namely CoWin and Aarogya Setu, to book their slots for taking the vaccine jab. For those above the age of 18, coronavirus vaccination will start from 1 May. People above the age of 18 can take the following steps to register for the vaccination: Step 1 : Open the play store to download the CoWin app or visit CoWin.gov.in Step 2 : Register on the portal using your mobile number. You will receive an OTP. Enter it to complete the registration Step 3 : You will have to enter your personal details including the number of your photo identification Step 4 : After the registration, select the date, time, and venue for your COVID-19 vaccination Step 5 : Visit the vaccination centre with your appointment slip and receive your first jab Once a person receives the first jab, th...
Post a Comment
Read more

India plans to import next batch of cheetahs from Northern Africa

India is considering importing cheetahs from northern Africa due to concerns that some of these big cats from Namibia and South Africa have developed a winter coat in Indian summer, officials said on Wednesday. According to officials, one of the biggest challenges faced in the first year of managing cheetahs in India was the unexpected development of winter coats by some cheetahs during the Indian summer and monsoon, in anticipation of the African winter (June to September). Even African experts did not expect it, a senior forest official said. The winter coat, combined with high humidity and temperatures, caused itching, prompting the animals to scratch their necks on tree trunks or the ground. This led to bruises and exposed skin, where flies laid their eggs, resulting in maggot infestations and, ultimately, bacterial infections and septicaemia, leading to the death of three cheetahs, the official explained. “Cheetahs in northern and north-eastern Africa, which is in the northern...
Post a Comment
Read more

India vs Australia World Cup Finals Today: How to Watch Live Stream, Telecast, Score

India vs Australia World Cup 2023 Finals is scheduled to take place today on November 19 at the Narendra Modi Stadium (Motera Stadium) in Ahmedabad, Gujarat. It will be a deja vu for all cricket fans after 20 long years as the two teams last played a World Cup Finals in 2003, where Australia defeated team India to become the world champions. from Gadgets 360 https://ift.tt/5DIZkQ0
Post a Comment
Read more